品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | S129877-5mg | 5mg | 现货 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
阿拉丁 | S129877-10mg | 10mg | 现货 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
阿拉丁 | S129877-50mg | 50mg | 现货 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
阿拉丁 | S408073-1ml | 1ml | 现货 | 202825-46-5 |
Safinamide Mesylate Safinamide Mesylate |
10mM in DMSO |
|
|
麦克林 | S833224-5mg | 5mg | 订前询问 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
≥98% (HPLC) |
|
|
麦克林 | S833224-10mg | 10mg | 订前询问 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
≥98% (HPLC) |
|
|
麦克林 | S833224-50mg | 50mg | 订前询问 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
≥98% (HPLC) |
|
|
麦克林 | S833224-250mg | 250mg | 订前询问 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
≥98% (HPLC) |
|
|
麦克林 | S833224-1g | 1g | 订前询问 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
≥98% (HPLC) |
|
|
罗恩 | R012475-10mg | 10mg | 现货 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
罗恩 | R012475-50mg | 50mg | 现货 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
罗恩 | R012475-5mg | 5mg | 现货 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
MARY | MR123586-10mg | 10mg | 订前咨询 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
MARY | MR123586-5mg | 5mg | 订前咨询 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
MARY | MR123586-50mg | 50mg | 订前咨询 | 202825-46-5 |
沙芬酰胺甲磺酸盐 Safinamide Mesylate |
98% |
|
|
源叶 | S44278-5mg | 5mg | 期货,请咨询 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
源叶 | S44278-10mg | 10mg | 期货,请咨询 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
源叶 | S44278-50mg | 50mg | 期货,请咨询 | 202825-46-5 |
Safinamide甲磺酸盐 Safinamide Mesylate |
≥98%(HPLC) |
|
|
源叶 | S59575-1ml | 1ml | 期货,请咨询 | 202825-46-5 |
Safinamide Mesylate Safinamide Mesylate |
10mM in DMSO |
|
|
毕得 | BD224314-1g | 1g | 现货 | 202825-46-5 |
(S)-2-((4-((3-氟苄基)氧基)苄基)氨基)丙... (S)-2-((4-((3-Fluorobenzyl)o... |
99% |
|
|